Aspects on the Role of the Pathologist in CRC

Slides:



Advertisements
Similar presentations
Is there a role for surgery in metastatic colorectal cancer?
Advertisements

Dept. Surgery, Colorectal unit, University Hospital, Uppsala, Sweden
Pre-operative Imatinib for metastatic, recurrent and locally advanced GISTs E. Efthimiou, S Mudan E. Efthimiou, S Mudan On behalf of the Sarcoma Group.
Breast Cancer Patient Issues in Family Practice: An Interactive Session.
OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
EQUS Conference - Brussels, June 16, 2011 Ambros Uchtenhagen, Michael Schaub Minimum Quality Standards in the field of Drug Demand Reduction Parallel Session.
CALENDAR.
Supported by ESRC Large Grant. What difference does a decade make? Satisfaction with the NHS in Northern Ireland in 1996 and 2006.
Professor Adrienne M Flanagan
Implementing NICE guidance
The 5S numbers game..
Neoadjuvant therapy for Rectal cancer
WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 YSBYTY GWYNEDD (YG) MDT.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experience of Research Findings and Opportunities From NCPES (National.
Contemporary practice of radiotherapy post radical prostatectomy at a tertiary referral centre in Australia Introduction  Adverse features on histopathology.
Before Between After.
Geraldine O’Dowd Consultant Pathologist NHS Lanarkshire 18 th November 2014 Colorectal Cancer Pathology: Impact of new guidelines for the laboratory.
Patient Survey Results 2013 Nicki Mott. Patient Survey 2013 Patient Survey conducted by IPOS Mori by posting questionnaires to random patients in the.
FDG-PET/CT PATTERNS AND PREVALENCE OF PERITONEAL SPREAD IN OVARIAN CANCER Srour SF 1, Bar-Shalom R 2 Srour SF 1, Bar-Shalom R 2 1 Department of Diagnostic.
Taunton SpR Training Day 7th December 2012 Early rectal cancer
Results of the Prodige 2-ACCORD 12/0405 Randomized trial comparing two neoadjuvant chemo-radiotherapy (Cape 45 vs Capox 50) in patients with T3-4 rectal.
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
Polyps – Where do they come from and what do you do with them?!
AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
T Staging: Rectal cancer T1 invades submucosa T2 invades muscularis propria T3 invades subserosa or perirectal tissues T4 invades peritoneum, organs or.
Rectal Cancer: A Complete Clinical Response…Now what?
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
Impact of Lymph-Node Metastatic Site in Patients with Thoracic Esophageal Cancer Edited by: Kunisaki C., Makino H., Kimura J., Oshima T., Fujii S., Takagawa.
Joint Hospital Surgical Grand Round KL FOK NDH/AHNH Department of Surgery.
CRITICAL READING OF THE LITERATURE RELEVANT POINTS: - End points (including the one used for sample size) - Surrogate end points - Quality of the performed.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Histopathological evaluation of lymphatic nodules in cancer of the uterine cervix Coordinators: First Author: Asist. Univ. Dr. Chira Liliana Stud. Bogdan.
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
CR07 results and informed patient consent David Sebag-Montefiore Leeds Cancer Centre.
TME trial TME radiotherapy 5 x 5 Gy TME alone randomisation n = 1861 resectable rectal carcinoma if CRM+: 50 GY.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Preoperative chemoradiotherapy and postoperative chemotherapy with 5-FU and oxaliplatin versus 5-FU alone in locally advanced rectal cancer: First results.
Pathologist and Prognosis in Colorectal Cancer Surgery. Dr Bryan F Warren Consultant Gastrointestinal Pathologist Oxford M62 Course 2004.
Accuracy of EUS in diagnosis of rectal cancer KKUH experience
Local recurrence after rectal cancer resection is strongly related to the plane of surgical (PoS) dissection and is further reduced by pre-operative short.
T Staging: Rectal cancer T1 invades submucosa T2 invades muscularis propria T3 invades subserosa or perirectal tissues T4 invades peritoneum, organs or.
Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.
Extra-Abdominal Fibromatosis : The Birmingham Experience
Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
Basingstoke Colorectal The Particular Problem of Low Rectal Cancer Brendan Moran Basingstoke 4 th East-West Colorectal Days Hungary 2008.
Role of MRI in Primary Rectal Cancer Staging and Management
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.
RECTAL CARCINOMA AND PREOPERATIVE MRI: USING A NATIONAL DATASET FOR REGIONAL AUDIT South West Cancer Intelligence Service J Weeks
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Non-operative Management of Rectal Cancer
นายแพทย์ธราธร ตุงคะสมิต นายแพทย์ชำนาญการพิเศษ โรงพยาบาลมะเร็งอุดรธานี
EMT inducing transcription factor SIP1: a predictive biomarker of colorectal cancer survival and recurrence? A Patel, R Sreekumar, R Bhome, KA Moutasim,
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
Dr Jessica Jenkins Consultant Oncologist
Effect of Neoadjuvant Concurrent Chemoradiotherapy on Locally Advanced Middle and Low Rectal Cancer— A Propensity Score Matching Study 官泰全,林春吉,楊純豪,姜正愷,林宏鑫,藍苑慈,
The STAR-TREC Trial SIV Presentation
Changes in TNM 8 To be used from
Presentation transcript:

Aspects on the Role of the Pathologist in CRC Najib Haboubi FRCS FRCP FRCPath D Path Professor of Health Sciences, Liver and Gastrointestinal Pathology. University Hospital of South Manchester UK

Selected Topics Multi Disciplinary Meeting(MDT). Resection Margins (Long and Circumferential). Assessment after CRT for Rectal Cancer

Background In UK (60m) there are 35,000 new cases and 16,000 deaths per annum. New patterns in some parts of the world. In India 6th commonest among female and 9th amongst male.

Accurate Pathological Reporting Confirm diagnosis. Inform prognosis. Plan treatment of individual patients. Audit pathology services. Evaluate and audit the quality of other services like radiology, surgery and oncology. Collect accurate data for cancer registration and epidemiology. Facilitate high quality research. Plan service delivery.

Multi Disciplinary Team (MDT) Colorectal Surgeons Radiologists. Pathologists. Oncologists. Specialist Nurse. Hepatobiliary(Thoracic) Surgeon Stoma Nurse. Clinical geneticist / counsellor. Social worker. Clinical trials coordinator or research nurse. GP Dietician. Gastroenterlogist

Video Conferencing

MDT Takes place at regular intervals Encourages a more efficient and team working atmosphere . Have a consensus approach to treatment according to agreed protocols. Quick and appropriate referral pattern. Audit surgical treatment. Audit pathology reports.

Evidence Based

Second Edition 2007 Few important additions. www.rcpath.org

Assessment of RM Longitudinal Circumferential / lateral /Radial / non peritonealised resection margin.

Minimum safe Longitudinal Margin 5 3 2 1 < 1cm

Reappraisal of 5 cm rule of distal excision for carcinoma of rectum Williams , Dixon and Johnston. Br.J.Surgery 1983

Conclusion The application of the 5 cm rule of distal excision may cause patients with low rectal cancer to lose their anal sphincter unnecessarily.

Kirwan , Drumm, Hogan, Keohane Determining safe margin of resection in low anterior resection for rectal cancer. Br.J.Surg 1988 1cm

Declining indication for APR resection in favour of AR Kirwan , O’Riordain and Waldron….. Br.J.Surg 1989

Karanjia, Schache, North and Heald ‘Close shave’ in anterior resection. Br.J.Surg. 1990 <1cm V >1cm

Conclusion Reduction of resection margins (provided TME and washout is properly performed) does not increase local recurrence or compromise survival.

DCR 2011

Conclusion Does not influence Oncological outcome

Additions in the 2nd edition (1) Documentation type of procedure . For rectal cancer, it is expected to have more AP than APR .

National Audit AR 1670 APR 746 Hartman’s 299 There is a trend of increase the AR over APR due to: Better preoperative treatment Better imaging modalities and Better surgery . Good surgeons should be able to undertake AR for tumours above 5cm from anal verge.

Currently Increasingly there are surgeons who practice restorative surgery for ‘ultra’ low rectal cancer: 3 cm

Circumferential (CRM) / Lateral / Radial / Non Peritonealised Resection Margin (NPRM)

Circumferential resection margin Involvement (CRMI) 1mm or less High Local Recurrence. Low Survival. Poor Standard of Surgery. Aggressive Disease. Tumour Location. Male gender.

Addition to the 2nd edition (2) Grading of surgical plane of resection in rectal cancer. The continuous feedback to surgeons may lead to improve quality of surgery.

Macroscopic Evaluation of Rectal cancer Resection Specimens Clinical Significance of the Pathologist in Quality Control. 2 years follow up. Iris Nagtegaal et al J Clin Oncol 2002, 20: 1729-1734

Macroscopic Grading of TME A (3) ( Good). Complete. Smooth, no coning, defect >5 mm and regular CRM C (1) ( Poor). Defects down to the Muscularis ,conning, no bulk and irregular CRM B(2) .Nearly complete. Defect present but Muscularis is not apparent(except at the insertion of LA) and irregular CRM.

Results Grade A&B - good and acceptable C- Poor Local Recurrence 8.7% 15% Local recurrence and Distant Metastasis 20.3% 36.1% 2 Year Survival 90.5% 76.9%

Addition to the 2nd edition (3) Measurement of tumour beyond the muscularis propria recorded in mm. This is to: a/ facilitate audit of preoperative imaging of extramural spread as it is of importance in selecting patients of rectal cancer to choose a therapy arm . b/ It has a prognostic implication for rectal cancer. 5mm or more is associated with adverse prognosis.

Addition to the 2nd edition (4) Recording tumour involvement of the NPRM in colonic tumours (in addition to rectum) like the caecum. These patients may be selected for post operative adjuvant therapy. Bateman et al J Clin Path 2005 and Quirke et al 2006 J Path

Addition to the 2nd edition (5) Recording serosal ( peritoneal surface) involvement. ‘Tumour cells visible either on the peritoneal surface or free in the peritoneal cavity carry bad prognosis’

Shepherd, Baxter and Love J. Clin. Path 1995 Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. Shepherd, Baxter and Love J. Clin. Path 1995

Local Peritoneal Involvement Detected in 25.8% (54/209) of cases. Showed considerable prognostic disadvantage in curative and non curative cases. May be an important factor in local recurrence of upper rectal cancers.

The Prognostic Importance of Peritoneal Involvement in Colonic Cancer: a Prospective Evaluation Shepherd et al Gastroenterology 1997 Strong predictive value for local recurrence / persistent disease specially when there is mucinous differentiation.

Additions in the 2nd edition (6) Recording of marked or complete tumour regression in patients with rectal cancer that have received adjuvant chemo / radiotherapy (CRT)

Rectal cancer that have received adjuvant R/CRT. Tumour regression is associated with improved prognosis.

Pathologist should record marked or CTR Rectal cancer that have received adjuvant R/CRT. Tumour regression is associated with improved prognosis.

1895 XRT 1st used

BMJ 1897

Rationale for combined CRT for Rectal Cancer Chemotherapy increases tissue sensitivity towards radiation. Radiation stops proliferation. Both tumourus and non tumourus tissue are affected.

Changes afflicting Tumour

Three folds decrease in local recurrence. Short course preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer Iris Nagtegaal et al. J Path 2002,197:20-27. 1306 patients(706 TME alone, 598 TME+RT) No change in stage (No change in depth and although there is decrease in no. of LN retrieval but not in +ve lymph nodes)!! Three folds decrease in local recurrence.

Long course CRT Improves staging (depth and LN status). Associated with c&pCTR

Classifications of Regression Mandard : Cancer 1994,73;2680. (1-5) Dworak : Int CRD 1997,12;19. (0-4) Wheeler : DCR 2002,45;1051. (1-3) Ryan : Histopathol 2005,47;141.(1-3) PRINCIPLE Tumour Volume V Fibrosis.

Discrepancy in Staging Author Grade Best Response (pCR) Worst Response Mandard 1-5 1 5 Dworak 0-4 4 Wheeler 1-3 3 Ryan

Ryan’s modification of Mandard’s 5 point system G1: No viable cancer cells (pCTR) : Single cells or small groups of cancer cells. G2: Residual cancer cells outgrown by fibrosis. G3: Significant fibrosis outgrown by cancer cells. : No fibrosis with extensive residual cancer.

Rayan et al Histopathology:2005,47:141-146. 60 patients G1, G2,G3. Pathological response following long-course neoadjuvant CRT for locally advanced rectal cancer Rayan et al Histopathology:2005,47:141-146. 60 patients G1, G2,G3. none of the G1&2 (excellent and good) had local recurrence after mean 22 months.

CTR we must be clear either pathologic (pCR) or clinical (cCR) 15-30% achieve pCR 25-50% of cCR are confirmed as pCR at subsequent surgery.

What do we do when there is cCR?

Operative Versus Non Operative Treatment for Stage 0 Distal Rectal Cancer Following Chaemoradiation Therapy Long-term Results Angelita Habr-Gama, et al Ann Surgery 2004

Results 26.8% of patients who received CRT developed complete clinical tumour response (observational group). Full thickness biopsy? The five-year overall and disease-free survival rates were 88% and 83% in Resection Group and 100% and 92% in Observation Group

Conclusion Stage 0 rectal cancer disease is associated with excellent long-term results irrespective of treatment strategy. Surgical resection may not lead to improved outcome in this situation and may be associated with high rates of temporary or definitive stoma construction and unnecessary morbidity and mortality rates.

Complete Clinical response After Preoperative CRT in Rectal cancer Is Wait and See Policy Justified? Glynne-Jones et al DCR 2008 Narrative Review of 246 studies

Results The end point of complete clinical response is inconsistently defined. Insufficiently robust. Partial concordance with pathological complete response.

Conclusion The rationale of ‘wait and see’ policy when complete clinical response status is achieved relies on retrospective observations which are insufficient to support such policy. EXCEPT In patients who are recognised as unfit or refused surgery

What do we do when there is cCR? There are at least one trial in UK and an audit in the North West Region. Registering ALL cases with cCR and cPR. Outcome?

`

The effective management of CRC requires The involvement of the histopathologist at various stages of treatment pathway. Diagnostic. Therapeutic. Audit. Research.

FACTORS INFLUENCING BIOLOGICAL RESPONSE Related to host and tissue. Related to therapy

Factors related to therapy Dose . High dose more toxic Field. Large field more toxic. Concomitant chemotherapy is more toxic Post operative RT is more toxic than pre operative RT

MORPHOLOGY

Acute radiation colitis in patients treated with short term preoperative radiotherapy for rectal cancer Leupin et al (Switzerland) Am J Surg. Path. 2002

Radiation colitis Long Course Short Course Sever mucosal inflammation. Prominent eosinophils. Crypt disarray Crypt epithelial damage. Nuclear abnormality Apoptosis of crypt epithelium. Either clinically silent or quick recovery. Long Course These features are either absent or rarely detected.

Haboubi, Rowland, and Schofield The Light and Electron Microscopic Features of Early and Late Radiation-Induced Proctitis Haboubi, Rowland, and Schofield Am.J.of Gastro. 1988

Conflicts in the literature

How SC differs from LC in pathological and clinical parameters 78 patients(SC 65, LC13) Age 38-85 (average 67 years) 54 males and 25 females Mean follow up 56 months(4-105) AR in 31 cases; APR in 47cases.

Results 1 32 Responders (Ryan grade 1 and 2) 10(76%) of LC vs. 22(33%)SC.

Results 2 7 patients had local recurrence (6SC,1LC) Regression did not correlate with local recurrence

Result 3 Regression did not correlate with overall survival

Prognostic Significance of Tumour Regression After Preoperative CRT for RC Rodel et al .J Clin Oncol 2005,23:8688 G 4 (Good) in 10.4% DFS 86%. G 2&3 DFS 75% G 0&1(Bad) >10% DFS 63%

Result 4 Overall mortality correlated with lymph node positivity (p=0.009) 29% of responders were LN+ve versus 48% non responders

Absence of LN in the resected specimen after Radical Surgery for Distal Rectal Cancer and Neoadjuvant CRT: What does it mean? Habr-Gama et al DCR 2008,51;277-283 32(11%) patients had no LN.5YDFS 74% 171(61%) had ypNO. 5YDFS 59% 78(28%) had yp(N+). 5YDFS 30%